RECRUITINGOBSERVATIONAL
GDF-15 and Early Outcomes After LVAD Implantation
Association of Preoperative GDF-15 Levels With Early Postoperative Outcomes and Mortality After LVAD Implantation
About This Trial
This observational study aims to investigate the association between preoperative GDF-15 levels and early postoperative outcomes in patients undergoing left ventricular assist device (LVAD) implantation. The study will evaluate whether elevated preoperative GDF-15 levels are associated with adverse early outcomes, including postoperative complications and mortality. The findings may help improve preoperative risk assessment and identify high-risk patients before LVAD implantation.
Who May Be Eligible (Plain English)
Who May Qualify:Adults aged 18 years and older
Patients with advanced heart failure undergoing LVAD implantation
Availability of preoperative GDF-15 measurement
Ability to provide written willing to sign a consent form or consent provided by a legally authorized representative, according to local regulations -
Who Should NOT Join This Trial:Age under 18 years
Active infection
Active malignancy
Severe hepatic failure
Missing study data
Refusal to participate
\-
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:Adults aged 18 years and older
Patients with advanced heart failure undergoing LVAD implantation
Availability of preoperative GDF-15 measurement
Ability to provide written informed consent or consent provided by a legally authorized representative, according to local regulations -
Exclusion Criteria:Age under 18 years
Active infection
Active malignancy
Severe hepatic failure
Missing study data
Refusal to participate
\-
Locations (1)
Akdeniz University, Faculty of Medicine, Department of Anesthesiology and Reanimation
Antalya, Please Select:, Turkey (Türkiye)